{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:40:08Z","timestamp":1744447208890,"version":"3.40.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcyt.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T09:21:21Z","timestamp":1735032081000},"page":"457-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide"],"prefix":"10.1016","volume":"27","author":[{"given":"Alexander","family":"Nikoloudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-4614","authenticated-orcid":false,"given":"Anna","family":"Bauhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Griessl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Groiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Milanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Buxhofer-Ausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Aichinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hasengruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Kaynak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Wipplinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Strassl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Stiefel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Rumpold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Machherndl-Spandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Weltermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2729-9706","authenticated-orcid":false,"given":"Johannes","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","article-title":"The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia","volume":"103","author":"Cook","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0002","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2005.05797.x","article-title":"Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation","volume":"131","author":"Giebel","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0003","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","article-title":"Natural killer cell education and tolerance","volume":"142","author":"Orr","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0004","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","article-title":"Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors","volume":"174","author":"Leung","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0005","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0006","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbmt.2006.04.008","article-title":"KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy","volume":"12","author":"Hsu","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0008","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","article-title":"Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors","volume":"102","author":"Giebel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0009","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2141.2005.05513.x","article-title":"Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma","volume":"129","author":"Kr\u00f6ger","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0010","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2004-04-1441","article-title":"Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias","volume":"105","author":"Beelen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0011","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood-2003-11-3893","article-title":"Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors","volume":"103","author":"Bornh\u00e4user","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0012","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0013","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbmt.2006.05.007","article-title":"The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry","volume":"12","author":"Farag","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0014","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-0039.2005.00396.x","article-title":"Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants","volume":"65","author":"De Santis","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2249.2007.03360.x","article-title":"Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation","volume":"148","author":"Clausen","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0017","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/bmt.2011.187","article-title":"Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors","volume":"47","author":"Clausen","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0018","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.4049\/jimmunol.1302517","article-title":"Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia","volume":"192","author":"Cooley","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0019","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/sj.leu.2403839","article-title":"A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation","volume":"19","author":"Verheyden","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humimm.2007.01.019","article-title":"Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation","volume":"68","author":"McQueen","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0021","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2007-01-065383","article-title":"Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT","volume":"109","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/bmt.2008.432","article-title":"KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12\/12 HLA matched, hematopoietic stem cell transplantation","volume":"44","author":"Ludajic","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0023","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2009-07-229740","article-title":"NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation","volume":"115","author":"Bj\u00f6rklund","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0024","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.bbmt.2015.05.002","article-title":"Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation","volume":"21","author":"Sobecks","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5020013","article-title":"HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation","volume":"5","author":"Clausen","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0026","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0027","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.178.6.3918","article-title":"Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor","volume":"178","author":"Fischer","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0028","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2002-08-2568","article-title":"Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation","volume":"101","author":"Shilling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0029","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0030","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0031","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0033","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.04.028","article-title":"Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients","volume":"27","author":"Nikoloudis","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1350470","article-title":"Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight","volume":"15","author":"Schetelig","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0036","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.molimm.2004.07.037","article-title":"KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation","volume":"42","author":"Malmberg","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2017.00041","article-title":"Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033871","article-title":"Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy","volume":"13","author":"Zou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0039","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/01.TP.0000137103.19717.86","article-title":"Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation","volume":"78","author":"Schaffer","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0040","article-title":"Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand","volume":"28","author":"Solomon","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0041","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.humimm.2022.07.006","article-title":"Donor selection based on NK alloreactivity for patients with hematological malignancies","volume":"83","author":"Jennifer Zhang","year":"2022","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.02.008","article-title":"A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors","volume":"28","author":"Otegbeye","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jcyt.2024.12.003_bib0043","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:24:35Z","timestamp":1744446275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924009460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1465324924009460"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}